Liver function and drug processing: a closer look at mirdametinib

NCT ID NCT06997276

First seen Apr 07, 2026 · Last updated May 13, 2026 · Updated 6 times

Summary

This study looks at how the drug mirdametinib is absorbed and removed from the body in people with moderate or severe liver problems compared to those with healthy livers. It involves 32 adults aged 18 to 80. The goal is to gather information, not to treat any condition.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • American Research Corporation (Texas Liver Institute)

    RECRUITING

    San Antonio, Texas, 78215, United States

  • Clinical Pharmacology of Miami

    RECRUITING

    Miami, Florida, 33014, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Orlando Clinical Research Center

    RECRUITING

    Orlando, Florida, 32809, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.